Cutaneous lupus erythematosus – Basic Information

Go back

Cutaneous lupus erythematosus is an autoimmune condition where the immune system attacks the skin, causing chronic inflammation and distinctive rashes that often worsen with sunlight exposure. While it shares a name with systemic lupus, cutaneous lupus primarily affects the skin and can occur independently or develop into more widespread disease. Understanding this condition helps patients better manage their symptoms and protect their skin from triggers.

Understanding Cutaneous Lupus Erythematosus

Cutaneous lupus erythematosus, often called skin lupus, is an autoimmune disease, meaning the body’s defense system mistakenly identifies its own skin cells as threats and attacks them. This attack leads to ongoing inflammation in the skin, which shows up as various types of rashes and skin changes. Unlike systemic lupus erythematosus (SLE), which can affect joints, blood vessels, kidneys, and other organs throughout the body, cutaneous lupus focuses its impact on the skin.[1]

The relationship between cutaneous lupus and systemic lupus is complex. Some people have only skin symptoms and never develop other organ involvement. Others may start with skin problems and later develop systemic disease. In fact, cutaneous lupus is actually two to three times more common than systemic lupus, showing that many people experience this condition without their whole body being affected. However, up to 75% of people with systemic lupus will develop skin symptoms at some point, and for about 25% of systemic lupus patients, skin changes may be the very first sign that something is wrong.[1][3][7]

Types of Cutaneous Lupus

Healthcare providers classify cutaneous lupus into different types based on how long symptoms last and what the skin lesions look like. Understanding these types helps doctors choose the right treatment and predict how the condition might progress.

Chronic cutaneous lupus causes steady, ongoing skin symptoms that may improve or worsen but typically don’t disappear completely. The lesions from this type often leave permanent scars or areas where the skin color has changed. The most common form is discoid lupus, named for the coin-shaped sores it creates. These thick, red, scaly patches usually appear on sun-exposed areas like the cheeks, nose, and ears. When discoid lupus affects the scalp, it can destroy hair follicles and cause permanent hair loss in those areas.[1][6]

Other forms of chronic cutaneous lupus include lupus profundus (also called lupus panniculitis), which affects the deeper fatty tissue beneath the skin and creates firm nodules. When these heal, they may leave indented scars due to destruction of fat cells. Chilblain lupus and lupus tumidus are additional chronic forms that present with their own characteristic patterns.[1][6]

Acute cutaneous lupus is a lifelong condition, but symptoms appear suddenly and then disappear for periods of time. The most recognizable form is the malar rash, also called a butterfly rash because it spreads across both cheeks and the bridge of the nose in a butterfly shape, while typically sparing the folds beside the nose. This rash often looks like severe sunburn and can range from mild redness to intense, itchy inflammation. Acute cutaneous lupus doesn’t usually leave scars when it heals, though it may temporarily change skin color.[1][3]

Subacute cutaneous lupus appears repeatedly for limited periods, often triggered by seasonal sun exposure. About 50% of people with this type have mild systemic lupus, and researchers believe that 20-40% of cases may be triggered by medications, particularly certain heart drugs, proton pump inhibitors used for stomach acid, antifungals, and some cancer treatments. This type creates either ring-shaped red patches with scaly borders and lighter centers, or raised scaly bumps that can resemble psoriasis. These lesions usually appear on the trunk, upper back, neck, chest, and arms. When they heal, they leave changes in skin color and tiny visible blood vessels, but typically no scarring.[3][15]

⚠️ Important
Long-standing discoid lupus lesions, especially those affecting the mouth or lips, can potentially develop into skin cancer over time. Regular monitoring by a healthcare provider is important to catch any concerning changes early. Proper sun protection and following your treatment plan can help reduce this risk.

Who Gets Cutaneous Lupus Erythematosus

Cutaneous lupus erythematosus has an annual incidence of about 4 cases per 100,000 people, with a prevalence of 73 cases per 100,000 in the general population. This means that while it’s not extremely common, it affects a significant number of people worldwide.[3]

Like systemic lupus, cutaneous lupus shows a strong preference for women. It particularly affects women between the ages of 20 and 50, with females developing the condition approximately twice as often as males. However, this doesn’t mean others are immune—all age groups and both sexes can develop cutaneous lupus. The peak onset typically occurs during a person’s third and fourth decades of life, though cases can appear earlier or later.[3][7]

Race and ethnicity play an important role in who develops cutaneous lupus. Having darker skin is an important predisposing factor. African Americans appear more likely to develop discoid lupus than Caucasians. Interestingly, the pattern reverses for subacute cutaneous lupus, with about 85% of those patients being Caucasian. People of Asian and Latino descent also show higher rates of lupus compared to the general population.[3][6][7]

Despite genetic factors playing a role, the vast majority of people with cutaneous lupus don’t have close relatives with systemic lupus. While the condition can run in families, most cases appear without a clear family history.[7]

What Causes Cutaneous Lupus Erythematosus

The development of cutaneous lupus involves a complex network of factors working together. Scientists believe it requires a combination of genetic susceptibility, environmental triggers, and problems with how the immune system functions.

Genetics clearly plays a role. Certain genes, particularly those involved in how the immune system recognizes proteins (called major histocompatibility complex genes), appear more frequently in people with cutaneous lupus. Families with lupus cases show higher incidence among relatives, suggesting inherited vulnerability. However, having these genes doesn’t guarantee someone will develop the condition—they simply increase the risk.[3][7]

Environmental factors serve as powerful triggers. Sunlight exposure stands out as one of the most important activators of cutaneous lupus. Ultraviolet (UV) light radiation from the sun causes skin cells to die. In people with cutaneous lupus, these dying cells become targets for autoantibodies—abnormal antibodies that attack the body’s own proteins instead of foreign invaders. UV light also triggers the release of signaling molecules called cytokines, which recruit inflammatory cells to the area and amplify the immune response. This explains why lupus rashes often appear or worsen on sun-exposed areas like the face, neck, arms, and chest.[3][7]

Cigarette smoking represents another significant environmental risk factor. Smoking appears to trigger or worsen cutaneous lupus symptoms, though the exact mechanism isn’t fully understood. Certain medications can also induce lupus-like symptoms, particularly subacute cutaneous lupus. Additionally, viral infections may play a role in triggering the condition in susceptible individuals.[3][7]

Risk Factors for Developing Cutaneous Lupus

Several factors increase a person’s likelihood of developing cutaneous lupus erythematosus. Being female, especially during childbearing years, significantly raises risk. The hormonal changes women experience may contribute to this pattern, though researchers are still working to understand exactly how hormones influence the disease.

Race and ethnicity matter considerably. African Americans, Asians, and people of Latino descent face higher rates of lupus compared to Caucasians. The type of cutaneous lupus that develops may also vary by race, with African Americans more prone to discoid lupus.

Spending significant time in the sun without adequate protection increases risk, as UV radiation can trigger the initial development of cutaneous lupus in susceptible people and cause flares in those already diagnosed. People who work outdoors, live in sunny climates, or enjoy outdoor recreation without sun protection face higher exposure.

Smoking cigarettes amplifies risk both for developing cutaneous lupus and for more severe disease. Smokers with lupus often respond less well to treatments and experience more frequent flares. Having a family history of lupus or other autoimmune diseases also increases vulnerability, though most people with cutaneous lupus don’t have affected relatives.[3][6]

Recognizing the Symptoms

The symptoms of cutaneous lupus vary depending on which type a person has, but certain patterns appear frequently. The most common feature is red, scaly areas of skin that often look like coins or rings. These patches especially appear on areas exposed to sunlight—the face, ears, scalp, neck, upper chest, and arms. On people with darker skin tones, these rashes might appear purple or brown rather than red.[1]

The butterfly rash across the cheeks and nose is perhaps the most recognizable symptom. This distinctive pattern involves redness and swelling over both cheeks that spreads across the bridge of the nose while typically avoiding the creases beside the nostrils. It can range from a mild blush to intense, painful inflammation.[1]

Many people notice that their skin becomes extremely sensitive to sunlight, a condition called photosensitivity. Even brief sun exposure can trigger new rashes or make existing ones worse. This sensitivity affects daily life, requiring careful planning around outdoor activities.

After lesions heal, they often leave behind patches where the skin color has changed—either lighter or darker than the surrounding skin. These pigment changes can be distressing and may persist long after the active inflammation has resolved.[1]

Other common symptoms include itching or irritation of affected areas, though not all lesions itch. Swelling, particularly around the eyes, sometimes occurs. When cutaneous lupus affects the scalp, it can cause hair loss. If the inflammation damages hair follicles deeply, this hair loss may become permanent, leaving smooth, scarred patches where hair once grew.[1]

Mouth sores and sores inside the nostrils can develop, causing discomfort when eating or breathing. Some people experience additional skin symptoms like hives, a lacy purple pattern on the skin called livedo reticularis, or Raynaud’s syndrome, where fingers or toes turn white or blue in response to cold or stress. Tiny red or purple spots called petechiae, small visible blood vessels called spider veins, and redness of the palms can also occur.[1]

How to Prevent Flares and Protect Your Skin

While cutaneous lupus can’t always be prevented, people can take meaningful steps to reduce the frequency and severity of flares. Sun protection stands as the single most important preventive measure. Because UV radiation triggers and worsens cutaneous lupus symptoms, protecting skin from the sun becomes essential for disease management.

Avoiding sun exposure during peak intensity hours, typically between 10 AM and 4 PM, helps reduce UV exposure. When going outdoors is necessary, wearing protective clothing makes a significant difference. Long sleeves, long pants, and wide-brimmed hats provide physical barriers against UV rays. Some clothing manufacturers even make garments with special UV-protective fabric.[1][7]

Sunscreen application represents a critical daily habit. People with cutaneous lupus should use broad-spectrum sunscreen that protects against both UVA and UVB rays, with an SPF of at least 30. The sunscreen needs to be applied generously to all exposed skin and reapplied every two hours, or more frequently if swimming or sweating. Many dermatologists recommend physical (mineral) sunscreens containing zinc oxide or titanium dioxide, as these sit on top of the skin and physically block UV rays rather than absorbing them.[7][17]

Sunglasses that block UV rays protect the delicate skin around the eyes and may help prevent eye complications that can occur with lupus. Seeking shade whenever possible provides additional protection.

Stopping smoking or never starting is crucial. Cigarette smoking not only increases the risk of developing cutaneous lupus but also makes the disease harder to control and reduces the effectiveness of treatments. People who quit smoking often notice improvement in their symptoms over time.[3]

Learning to recognize personal triggers helps prevent flares. While sun exposure is nearly universal, some people notice that stress, certain medications, infections, or hormonal changes also trigger symptom worsening. Keeping a symptom diary can help identify patterns and allow for better planning and prevention strategies.

⚠️ Important
Tanning beds are never safe for people with cutaneous lupus. The UV radiation from tanning beds can trigger severe flares and cause significant skin damage. Indoor tanning should be completely avoided, regardless of claims about “safe tanning” or controlled UV exposure.

What Happens in the Body: Understanding the Disease Process

At the cellular level, cutaneous lupus involves a malfunction in how the immune system operates. Normally, the immune system produces antibodies that recognize and attack foreign invaders like bacteria or viruses. In autoimmune diseases like cutaneous lupus, this system goes awry and produces autoantibodies that target the body’s own healthy tissues.

In cutaneous lupus, these autoantibodies attack components of skin cells. When UV light hits the skin, it causes some cells to die through a normal process. In healthy people, the immune system quietly removes these dead cells without causing inflammation. In people with cutaneous lupus, however, the immune system recognizes these dying cells as threats and launches an attack against them.[7]

This immune response involves multiple players. T cells and B cells, two types of white blood cells, become activated and travel to the skin. B cells produce the problematic autoantibodies. The immune cells release inflammatory molecules called cytokines that attract even more immune cells to the area, creating a cycle of inflammation.

A particular type of immune signaling called the type I interferon pathway plays a central role in cutaneous lupus. Interferons are proteins normally produced to fight viral infections, but in lupus, they become overactive even without an infection present. This skewed interferon production contributes significantly to the chronic inflammation seen in lupus skin lesions.[9]

The inflammation damages the junction between the top layer of skin (epidermis) and the layer beneath it (dermis), creating what pathologists call vacuolar interface dermatitis—a key microscopic finding when diagnosing cutaneous lupus. Over time, this repeated inflammation can destroy skin structures like hair follicles, oil glands, and collagen, leading to scarring and permanent changes in skin texture and appearance.

In chronic forms like discoid lupus, the inflammation extends deeper and persists longer, which explains why these types cause more scarring than acute forms. The immune attack on hair follicles in the scalp destroys them completely, preventing hair regrowth even after the inflammation subsides.

Interestingly, research suggests that the basic disease process at the cellular level may be similar across different types of cutaneous lupus lesions. The differences in how the disease appears on the skin—whether as the butterfly rash of acute lupus or the thick, scaly plaques of discoid lupus—may relate more to where in the skin the inflammation occurs and how long it persists rather than fundamentally different processes happening.[9]

Ongoing Clinical Trials on Cutaneous lupus erythematosus

  • A Study of Anifrolumab for Patients with Cutaneous Lupus Erythematosus to Measure Changes in Skin and Blood Inflammation and Clinical Outcomes

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria
  • Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

    Recruiting

    4 1
    Investigated drugs:
    Belgium Bulgaria France Germany Hungary Italy +5
  • Study on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium Bulgaria France Germany Hungary Italy +5
  • Comparing lenalidomide and methotrexate for patients with difficult-to-treat cutaneous lupus erythematosus

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

    Not recruiting

    2 1 1
    Investigated drugs:
    Bulgaria Greece Poland Romania Spain
  • Study on IMVT-1402 for Patients with Active Cutaneous Lupus Erythematosus

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Germany Greece Poland Spain
  • Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Bulgaria Denmark France Germany Greece +7
  • Study of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)

    Not recruiting

    2 1
    Investigated drugs:
    Bulgaria Greece Poland Romania Spain
  • Study of GS-5718 for Patients with Cutaneous Lupus Erythematosus (CLE)

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Spain
  • Study of PF-06823859 for Adults with Active Cutaneous or Systemic Lupus Erythematosus with Skin Symptoms

    Not recruiting

    2 1
    Greece Spain

References

https://my.clevelandclinic.org/health/diseases/21601-cutaneous-lupus-skin-lupus

https://nyulangone.org/conditions/cutaneous-lupus/types

https://dermnetnz.org/topics/cutaneous-lupus-erythematosus

https://pmc.ncbi.nlm.nih.gov/articles/PMC3927537/

https://www.youtube.com/watch?v=qgiLWDosn-E

https://www.americanskin.org/resource/lupus.php

https://www.utsouthwestern.edu/departments/dermatology/research/cutaneous-lupus-registry/disease-faq.html

https://hightowerclinical.com/blogs/cutaneous-lupus-erythematosus/

https://pmc.ncbi.nlm.nih.gov/articles/PMC7357847/

https://my.clevelandclinic.org/health/diseases/21601-cutaneous-lupus-skin-lupus

https://emedicine.medscape.com/article/1065292-treatment

https://www.aad.org/public/diseases/a-z/lupus-treatment

https://dermnetnz.org/topics/cutaneous-lupus-erythematosus

https://nyulangone.org/conditions/cutaneous-lupus/treatments/medication-for-cutaneous-lupus

https://www.arthritis.org/diseases/more-about/cutaneous-lupus-symptoms-and-treatments

https://www.utsouthwestern.edu/departments/dermatology/research/cutaneous-lupus-registry/disease-faq.html

https://www.aad.org/public/diseases/a-z/lupus-self-care

https://www.rupahealth.com/post/living-with-cutaneous-lupus-tips-to-help-manage-your-skin

https://nyulangone.org/conditions/cutaneous-lupus/support

https://hightowerclinical.com/blogs/cutaneous-lupus-erythematosus/

https://www.summahealth.org/flourish/entries/2021/05/7-tips-to-living-better-with-lupus

https://my.clevelandclinic.org/health/diseases/21601-cutaneous-lupus-skin-lupus

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can cutaneous lupus turn into systemic lupus that affects internal organs?

Some people with cutaneous lupus do go on to develop systemic symptoms, though many never do. Cutaneous lupus is actually two to three times more common than systemic lupus, meaning most people with skin symptoms remain limited to skin involvement. Sometimes cutaneous lupus can be the first sign of systemic disease, which is why doctors monitor patients regularly and watch for symptoms beyond the skin.

Will the rashes and scars from cutaneous lupus ever go away completely?

It depends on which type of cutaneous lupus you have. Acute cutaneous lupus, including the butterfly rash, typically doesn’t leave scars when it heals, though it may temporarily change skin color. Subacute cutaneous lupus usually resolves without scarring but can leave pigment changes and tiny visible blood vessels. Chronic cutaneous lupus, especially discoid lupus, often causes permanent scarring, skin discoloration, and potentially permanent hair loss in affected areas.

Is cutaneous lupus contagious or can I pass it to my children?

Cutaneous lupus is not contagious—you cannot catch it from or spread it to other people through contact. However, genetics do play a role in susceptibility. While most people with cutaneous lupus don’t have affected relatives, having lupus does increase the likelihood that family members might develop autoimmune conditions. The vast majority of cutaneous lupus patients don’t have close relatives with systemic lupus.

Why does sunlight make my lupus rash worse?

Ultraviolet light from the sun causes skin cells to die, which is normal. However, in people with cutaneous lupus, these dying cells trigger an abnormal immune response where the body attacks them as if they were threats. UV light also causes the release of inflammatory molecules called cytokines that attract immune cells to the skin and amplify the inflammation. This is why sun protection is considered the most important preventive measure for people with cutaneous lupus.

Can smoking really affect my cutaneous lupus symptoms?

Yes, cigarette smoking significantly impacts cutaneous lupus. Smoking is an important environmental risk factor that can trigger or worsen symptoms. People who smoke with cutaneous lupus often respond less well to treatments and experience more frequent disease flares. Many people who quit smoking notice improvement in their symptoms over time, making smoking cessation an essential part of disease management.

🎯 Key takeaways

  • Cutaneous lupus is two to three times more common than systemic lupus, affecting primarily the skin rather than internal organs.
  • Sun protection is the single most important preventive measure—UV light triggers and worsens symptoms in most people with this condition.
  • Women aged 20-50 are most commonly affected, with females developing the condition about twice as often as males.
  • The classic butterfly rash across the cheeks and nose is characteristic of acute cutaneous lupus and typically doesn’t leave permanent scars.
  • Discoid lupus can cause permanent scarring and hair loss if it affects the scalp by destroying hair follicles.
  • Between 20-40% of subacute cutaneous lupus cases are triggered by medications, including common heartburn drugs and certain heart medications.
  • Smoking cigarettes worsens cutaneous lupus symptoms and reduces treatment effectiveness—quitting often leads to improvement.
  • Long-standing discoid lupus lesions, especially on the lips or mouth, can potentially develop into skin cancer and need regular monitoring.